Application of hRad9 in lung cancer treatment as a molecular marker and a molecular target

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• DNA damage sensor proteins are crucial for cell cycle control and apoptosis.
• hRad9, a DNA damage sensor, is an upstream regulator of checkpoint signaling.
• hRad9 accumulation in non-small cell lung cancer (NSCLC) nuclei suggests its role in tumor progression.

Approach:

• Investigated hRad9 protein levels in NSCLC tumor specimens.
• Assessed the functionality of hRad9 in lung cancer cells.
• Utilized RNA interference (RNAi) to target hRad9 and evaluate its impact on cancer cell viability.

Key Points:

• Significant accumulation of hRad9 was observed in the nuclei of NSCLC tumor cells.
• Lung cancer cells retain the capacity to produce functional hRad9 protein.
• Impairment of DNA damage checkpoint signaling via hRad9 targeting led to cancer cell death.

Conclusions:

• hRad9 is a vital component for NSCLC survival and progression.
• hRad9 represents a promising molecular target for controlling lung cancer cell growth.
• Targeting hRad9 may offer a novel therapeutic strategy for lung cancer treatment.